Number and percentage of IL10 promoter genotypes in the non-NP-SLE and NP-SLE patients, the combination of these groups, and controls
| Genotype | non-NP-SLE | NP-SLE | SLE | Controls | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| n | % | n | % | n | % | n | % | ||||||||
| GCC/GCC | 19 | 38 | 5 | 12 | 24 | 27 | 50 | 31 | |||||||
| GCC/ACC | 13 | 26 | 14 | 33 | 27 | 29 | 47 | 29 | |||||||
| GCC/ATA | 10 | 20 | 10 | 24 | 20 | 22 | 31 | 19 | |||||||
| ACC/ACC | 3 | 6 | 2 | 5 | 5 | 5 | 13 | 8 | |||||||
| ACC/ATA | 3 | 6 | 7 | 17 | 10 | 11 | 14 | 9 | |||||||
| ATA/ATA | 2 | 4 | 4 | 10 | 6 | 7 | 7 | 4 | |||||||
n: number of genotypes.